Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aplidine for multiple myeloma treatment

Aplidine for multiple myeloma treatment

US Patent 7381703 · Granted Jun 3, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substance applicator2025
Modulating gabarap to modulate immunogenic cell death2024
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
Methods for modulating regulatory T cells, regulatory b cells, and immune respon2024
Small molecules for inducing selective protein degradation and uses thereof2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Use of multi-frequency impedance cytometry in conjunction with machine learning 2023
Immunogenic peptides specific to BCMA and TACI antigens2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
USP7 inhibitors for treating multiple myeloma2022
Inhibitors of histone deacetylase2022